Evidence map›Paper›PMID 37899480›Full record

ReviewMilitary Medical Research2023

How to use the Surveillance, Epidemiology, and End Results (SEER) data: research design and methodology.

Wen-Qiang Che, Yuan-Jie Li, Chi-Kwan Tsang, Yu-Jiao Wang, Zheng Chen, Xiang-Yu Wang, An-Ding Xu, Jun Lyu

Abstract readReview
In one paragraph

Review in Military Medical Research, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 110 papers.

0numbers the graph read from it
0cells of the map it votes in
110citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

110 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

50 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Wen-Qiang Che *Department of Neurosurgery, the First Affiliated Hospital of Jinan University, Guangzhou, 510632, China.
Yuan-Jie Li *Planning & Discipline Construction Office, the First Affiliated Hospital of Jinan University, Guangzhou, 510632, China.
Chi-Kwan TsangClinical Neuroscience Institute, the First Affiliated Hospital of Jinan University, Guangzhou, 510632, China.
Yu-Jiao WangDepartment of Pathology, Shanxi Provincial People's Hospital, Taiyuan, 030012, China.
Zheng ChenDepartment of Urology, the First Affiliated Hospital of Jinan University, Guangzhou, 510632, China.
Xiang-Yu WangDepartment of Neurosurgery, the First Affiliated Hospital of Jinan University, Guangzhou, 510632, China. wang_xy123@126.com.
An-Ding XuDepartment of Neurology, the First Affiliated Hospital of Jinan University, Guangzhou, 510632, China. tlil@jnu.edu.cn.
Jun LyuDepartment of Clinical Research, the First Affiliated Hospital of Jinan University, Guangzhou, 510632, China. lyujun2020@jnu.edu.cn.ORCID 0000-0002-2237-8771

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In the United States (US), the Surveillance, Epidemiology, and End Results (SEER) program is the only comprehensive source of population-based information that includes stage of cancer at the time of diagnosis and patient survival data. This program aims to provide a database about cancer incidence and survival for studies of surveillance and the development of analytical and methodological tools in the cancer field. Currently, the SEER program covers approximately half of the total cancer patients in the US. A growing number of clinical studies have applied the SEER database in various aspects. However, the intrinsic features of the SEER database, such as the huge data volume and complexity of data types, have hindered its application. In this review, we provided a systematic overview of the commonly used methodologies and study designs for retrospective epidemiological research in order to illustrate the application of the SEER database. Therefore, the goal of this review is to assist researchers in the selection of appropriate methods and study designs for enhancing the robustness and reliability of clinical studies by mining the SEER database.

Indexed as

NeoplasmsResearch DesignHumansReproducibility of ResultsRetrospective StudiesSEER ProgramUnited StatesBig dataEpidemiologyMethodologiesStudy designSurveillance, Epidemiology, and End results (SEER)

Identifiers

PMID37899480
PMCPMC10614369

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.